Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

NCT00972881 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: capecitabine
DRUG: irinotecan hydrochloride
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery
RADIATION: radiation therapy

Sponsor

University College, London